1. Home
  2. VRDN vs RSI Comparison

VRDN vs RSI Comparison

Compare VRDN & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • RSI
  • Stock Information
  • Founded
  • VRDN 2006
  • RSI 2012
  • Country
  • VRDN United States
  • RSI United States
  • Employees
  • VRDN N/A
  • RSI N/A
  • Industry
  • VRDN Medical Specialities
  • RSI Services-Misc. Amusement & Recreation
  • Sector
  • VRDN Health Care
  • RSI Consumer Discretionary
  • Exchange
  • VRDN Nasdaq
  • RSI Nasdaq
  • Market Cap
  • VRDN 1.3B
  • RSI 1.3B
  • IPO Year
  • VRDN N/A
  • RSI N/A
  • Fundamental
  • Price
  • VRDN $18.54
  • RSI $19.50
  • Analyst Decision
  • VRDN Strong Buy
  • RSI Strong Buy
  • Analyst Count
  • VRDN 11
  • RSI 9
  • Target Price
  • VRDN $38.80
  • RSI $18.25
  • AVG Volume (30 Days)
  • VRDN 767.6K
  • RSI 2.1M
  • Earning Date
  • VRDN 08-06-2025
  • RSI 07-30-2025
  • Dividend Yield
  • VRDN N/A
  • RSI N/A
  • EPS Growth
  • VRDN N/A
  • RSI N/A
  • EPS
  • VRDN N/A
  • RSI 0.26
  • Revenue
  • VRDN $305,000.00
  • RSI $1,017,900,000.00
  • Revenue This Year
  • VRDN N/A
  • RSI $15.47
  • Revenue Next Year
  • VRDN $17,102.33
  • RSI $14.15
  • P/E Ratio
  • VRDN N/A
  • RSI $74.69
  • Revenue Growth
  • VRDN 5.90
  • RSI 26.99
  • 52 Week Low
  • VRDN $9.90
  • RSI $8.76
  • 52 Week High
  • VRDN $27.20
  • RSI $20.32
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.06
  • RSI 67.40
  • Support Level
  • VRDN $15.68
  • RSI $18.77
  • Resistance Level
  • VRDN $19.10
  • RSI $19.47
  • Average True Range (ATR)
  • VRDN 1.01
  • RSI 0.87
  • MACD
  • VRDN 0.08
  • RSI 0.02
  • Stochastic Oscillator
  • VRDN 83.63
  • RSI 83.92

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

Share on Social Networks: